These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 11205314

  • 1. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
    Nagy HJ, Panis Y, Fabre M, Klatzmann D, Houssin D, Soubrane O.
    Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced efficiency and specificity of ovarian cancer gene therapy in rats with a novel nonviral gene delivery system (GE7) via intraovarian artery perfusion approach.
    Jiang W, Xu CJ, Shao ZM, Zhou WJ, Ye B, Tian PK, Zhu JD, Gu JR.
    Cancer Gene Ther; 2005 Oct; 12(10):810-7. PubMed ID: 15905861
    [Abstract] [Full Text] [Related]

  • 4. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE, Yu HM, Liu RS, Lin M, Gelovani JG, Hwang JJ, Wei HJ, Deng WP.
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [Abstract] [Full Text] [Related]

  • 5. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration.
    Tong XW, Block A, Chen SH, Contant CF, Agoulnik I, Blankenburg K, Kaufman RH, Woo SL, Kieback DG.
    Gynecol Oncol; 1996 May; 61(2):175-9. PubMed ID: 8626129
    [Abstract] [Full Text] [Related]

  • 6. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR.
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [Abstract] [Full Text] [Related]

  • 7. Are hepatomas a good target for suicide gene therapy? An experimental study in rats using retroviral-mediated transfer of thymidine kinase gene.
    Nagy H, Panis Y, Fabre M, Perrin H, Klatzmann D, Houssin D.
    Surgery; 1998 Jan; 123(1):19-24. PubMed ID: 9457219
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K, Loimas S, Wahlfors J, Alhava E, Jänne J.
    J Gene Med; 2000 May; 2(5):361-7. PubMed ID: 11045430
    [Abstract] [Full Text] [Related]

  • 12. The equine herpes virus 4 thymidine kinase is a better suicide gene than the human herpes virus 1 thymidine kinase.
    Loubière L, Tiraby M, Cazaux C, Brisson E, Grisoni M, Zhao-Emonet J, Tiraby G, Klatzmann D.
    Gene Ther; 1999 Sep; 6(9):1638-42. PubMed ID: 10490775
    [Abstract] [Full Text] [Related]

  • 13. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 14. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J.
    Cancer Res; 1999 May 15; 59(10):2384-94. PubMed ID: 10344748
    [Abstract] [Full Text] [Related]

  • 15. Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK.
    Cowsill C, Southgate TD, Morrissey G, Dewey RA, Morelli AE, Maleniak TC, Forrest Z, Klatzmann D, Wilkinson GW, Löwenstein PR, Castro MG.
    Gene Ther; 2000 Apr 15; 7(8):679-85. PubMed ID: 10800091
    [Abstract] [Full Text] [Related]

  • 16. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
    Int J Oncol; 2004 Apr 15; 24(4):943-9. PubMed ID: 15010834
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
    Kokoris MS, Sabo P, Adman ET, Black ME.
    Gene Ther; 1999 Aug 15; 6(8):1415-26. PubMed ID: 10467366
    [Abstract] [Full Text] [Related]

  • 18. [Adenovirus-mediated herpes simplex virus thymidine kinase gene transference and combined drug therapy leads to apoptosis of human epithelial ovarian cancer cells].
    Jiang J, Kong B, Jiang S.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Dec 15; 35(12):736-9. PubMed ID: 11286034
    [Abstract] [Full Text] [Related]

  • 19. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 20. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME, Feng M, Michael SI, Siegal GP, Alvarez RD, Curiel DT.
    Clin Cancer Res; 1995 Dec 15; 1(12):1571-80. PubMed ID: 9815958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.